Condition: Elderly · Antineoplastic Agents · Sponsor: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
The CARTIER study is a randomized, multicenter, open-label clinical trial comparing, in elderly patients with cancer under anti-tumoral treatment, two different cardiotoxicity prevention strategies: primary (intensive cardiovascular monitoring focused on prevention and early diagnosis and treatment of cardiotoxicity based in cardio-onco-hematology teams involved in cancer patient care) vs. secondary (current clinical practice where intensive cardiovascular monitoring is not routinely performed and cardiotoxicity patient care is based on the onco-hematologist criteria). The primary endpoint is to determine whether this primary prevention englobing cardiovascular monitoring plus intensive multidisciplinary management is superior to the current clinical practice in reducing all cause mortality. Other secondary objectives of the study are to analyze the impact of this intensive cardiovascular monitoring strategy on the incidence of cardiovascular mortality, oncological mortality, hospitalization and/or urgent care due to cardiovascular complications, hospitalization and/or urgent oncological care due to cancer complications, tumor progression and cost-effectiveness analysis. A total of 514 patients ≥ 65 years old diagnosed with any of the following onco-hematological cancers, colon, breast, lymphoma, chronic lymphoma leukemia, chronic myeloid leukemia or myeloma, undergoing standardized anti-tumoral treatment, will be recruited. The incidence of primary and secondary outcomes…
This description comes directly from the study's public registry record.
Pedro L Sánchez, Ph. D. · 923 291100 · plsanchez@saludcastillayleon.es
Ana Martín-García, Ph. D. · 923 291100 · amartingarcia@usal.es
Always discuss trial participation with your own doctor first.
| Hospital Clínico Universitario de Santiago de Compostela | Santiago de Compostela, A Coruña, Spain | Not Yet Recruiting |
| Hospital de Galdakao-Usansolo | Galdakao, Vizcaya, Spain | Not Yet Recruiting |
| Hospital Universitario Vall d´Hebron | Barcelona, Spain | Not Yet Recruiting |
| Hospital Universitario Reina Sofía | Córdoba, Spain | Not Yet Recruiting |
| Hospital Universitario de La Princesa | Madrid, Spain | Not Yet Recruiting |
| Hospital G. Universitario Gregorio Marañón | Madrid, Spain | Not Yet Recruiting |
| Hospital Universitario Ramón y Cajal | Madrid, Spain | Not Yet Recruiting |
| Hospital Universitario Fundación Jiménez Díaz | Madrid, Spain | Not Yet Recruiting |
| Hospital Universitario 12 de Octubre | Madrid, Spain | Not Yet Recruiting |
| Hospital Universitario Puerta de Hierro | Madrid, Spain | Not Yet Recruiting |
| Hospital Universitario Virgen de la Victoria | Málaga, Spain | Not Yet Recruiting |
| Complejo Asistencial Universitario de Salamanca | Salamanca, Spain | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03711110